Clusin W T, Bristow M R, Karagueuzian H S, Katzung B G, Schroeder J S
Am J Cardiol. 1982 Feb 18;49(3):606-12. doi: 10.1016/s0002-9149(82)80019-2.
Calcium ions mediate the adverse effects of myocardial ischemia and have been implicated in the genesis of arrhythmias. Calcium influx blocking drugs protect against early ventricular arrhythmias during experimental coronary occlusion, and recent studies suggest that this effect is at least partly due to inhibition of myocardial cell calcium influx. Most of the pharmacologic maneuvers used to simulate acute ischemic arrhythmias in vivo also produce intracellular calcium overload. Production of calcium overload in small myocardial cell clusters causes fibrillatory electrical and mechanical activity similar to that recorded from fibrillating hearts. Fibrillation in these cell clusters is mediated not by reentrant conduction, but by the same subcellular processes that give rise to depolarizing afterpotentials and abnormal automaticity. Agents favoring calcium influx, such as beta adrenergic agonists, accentuate these processes, while agents that depress calcium influx inhibit them. Although the relation of these experimental models to clinical ischemic arrhythmias has not been fully delineated, calcium influx blocking drugs may prove useful in reducing the incidence of sudden cardiac death.
钙离子介导心肌缺血的不良反应,并与心律失常的发生有关。钙内流阻断药物可预防实验性冠状动脉闭塞期间的早期室性心律失常,最近的研究表明,这种作用至少部分归因于对心肌细胞钙内流的抑制。大多数用于在体内模拟急性缺血性心律失常的药理学操作也会导致细胞内钙超载。在小的心肌细胞簇中产生钙超载会导致类似于颤动心脏记录的颤动电活动和机械活动。这些细胞簇中的颤动不是由折返传导介导的,而是由引起去极化后电位和异常自律性的相同亚细胞过程介导的。促进钙内流的药物,如β肾上腺素能激动剂,会加剧这些过程,而抑制钙内流的药物则会抑制它们。尽管这些实验模型与临床缺血性心律失常的关系尚未完全阐明,但钙内流阻断药物可能被证明对降低心脏性猝死的发生率有用。